Expert Consensus on the Screening, Treatment, and Management of Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD), and the Potential Future Role of Anti-fibrotics[asterisk] in a Treatment Paradigm for SSc-ILD: A Delphi Consens
C101. NON-IDIOPATHIC INTERSTITIAL PNEUMONIA NATURAL HISTORY AND PROGNOSIS AND ILD THERAPY | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A7445-A7445
10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7445